BioTime has moved up by more than 30% in just last one week and Geron is stuck around $1.10! What does that tell you? One thing is proven: Wherever Okarma goes, he brings higher share price, curse him or not, isn't it? OR is it that Scarlett-Huh and company failed to judge the investor sentiment in favor of stem-cell prospects?
I don't know what stage Gerons cancer program is at, but i can tell you this about BTX....
Biotime is working with Cornell Weil, now in preclinical stage for cancer detection, here are some key facts:
-Subsidiary OncoCyte will have cancer detection product available in EU in the second half of 2014.
-Pre-clinicals underway for detection, therapeutics using nano-peptide cell targeting in R & D.
-Detection of up to 700 gene markers & proprietary RNA microarray technology, many genes never before associated with cancer.
-Antibody blood test capability....no radiation needed
You idiot, they keep selling the ATM into any buying pressure then let off when the buying slows. This keeps it above $1 so they don't get delisted. It also won't go up until they sell all the shares allocated, 50 million I think was the number.